Emerging clinical applications of RNA (original) (raw)

• Green, P. J., Pines, O. & Inouye, M. The role of antisense RNA in gene regulation. Annu. Rev. Biochem. 55, 569–597 (1986).
  Article CAS PubMed Google Scholar
• Pestka, S., Daugherty, B. L., Jung, V., Hotta, K. & Pestka, R. K. Anti-mRNA: specific inhibition of translation of single mRNA molecules. Proc. Natl Acad. Sci. USA 81, 7525–7528 (1984).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Coleman, J., Green, P. J. & Inouye, M. The use of RNAs complementary to specific mRNAs to regulate the expression of individual bacterial genes. Cell 37, 429–436 (1984).
  Article CAS PubMed Google Scholar
• Izant, J. G. & Weintraub, H. Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA. Science 229, 345–352 (1985).
  Article ADS CAS PubMed Google Scholar
• van der Krol, A. R., Mol, J. N. & Stuitje, A. R. Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques 6, 958–976 (1988).
  CAS PubMed Google Scholar
• Sullenger, B. A., Lee, T. C., Smith, C. A., Ungers, G. E. & Gilboa, E. Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol. Cell. Biol. 10, 6512–6523 (1990).
  CAS PubMed PubMed Central Google Scholar
• Kruger, K. et al. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147–157 (1982).
  Article CAS PubMed Google Scholar
• Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N. & Altman, S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849–857 (1983).
  Article CAS PubMed Google Scholar
• Uhlenbeck, O. C. A small catalytic oligoribonucleotide. Nature 328, 596–600 (1987).
  Article ADS CAS PubMed Google Scholar
• Haseloff, J. & Gerlach, W. L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585–591 (1988).
  Article ADS CAS PubMed Google Scholar
• Cech, T. R. Ribozymes and their medical implications. J. Am. Med. Assoc. 260, 3030–3034 (1988).
  Article CAS Google Scholar
• Usman, N. & Blatt, L. M. Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics. J. Clin. Invest. 106, 1197–1202 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Symons, R. H. Small catalytic RNAs. Annu. Rev. Biochem. 61, 641–671 (1992).
  Article CAS PubMed Google Scholar
• Bauer, G. et al. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood 89, 2259–2267 (1997).
  Article CAS PubMed Google Scholar
• Wong-Staal, F., Poeschla, E. M. & Looney, D. J. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum. Gene Ther. 9, 2407–2425 (1998).
  Article CAS PubMed Google Scholar
• Amado, R. G. et al. A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme. Hum. Gene Ther. 10, 2255–2270 (1999).
  Article CAS PubMed Google Scholar
• Sullenger, B. A. & Cech, T. R. Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262, 1566–1569 (1993).
  Article ADS CAS PubMed Google Scholar
• Lee, N. S., Bertrand, E. & Rossi, J. mRNA localization signals can enhance the intracellular effectiveness of hammerhead ribozymes. RNA 5, 1200–1209 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Beigelman, L. et al. Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J. Biol. Chem. 270, 25702–25708 (1995).
  Article CAS PubMed Google Scholar
• Wincott, F. et al. Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Res. 23, 2677–2684 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Pavco, P. A. et al. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors. Clin. Cancer Res. 6, 2094–2103 (2000).
  CAS PubMed Google Scholar
• Macejak, D. G. et al. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 31, 769–776 (2000).
  Article CAS PubMed Google Scholar
• Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  Article ADS CAS PubMed Google Scholar
• Sui, G. et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA 99, 5515–5520 (2002).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Miyagishi, M. & Taira, K. U6 promoter-driven siRNA with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnol. 20, 497–500 (2002).
  Article CAS Google Scholar
• Lee, N. S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol. 20, 500–505 (2002).
  Article CAS Google Scholar
• Paul, C. P. et al. Effective expression of small interfering RNA in human cells. Nature Biotechnol. 20, 505–508 (2002).
  Article CAS Google Scholar
• Guo, H. et al. Group II introns designed to insert into therapeutically relevant DNA target sites in human cells. Science 289, 452–457 (2000).
  Article ADS CAS PubMed Google Scholar
• Sullenger, B. A. & Cech, T. R. Ribozyme-mediated repair of defective mRNA by targeted, _trans_-splicing. Nature 371, 619–622 (1994).
  Article ADS CAS PubMed Google Scholar
• Jones, J. T., Lee, S. W. & Sullenger, B. A. Tagging ribozyme reaction sites to follow _trans_-splicing in mammalian cells. Nature Med. 2, 643–648 (1996).
  Article CAS PubMed Google Scholar
• Phylactou, L. A., Darrah, C. & Wood, M. J. Ribozyme-mediated _trans_-splicing of a trinucleotide repeat. Nature Genet. 18, 378–381 (1998).
  Article CAS PubMed Google Scholar
• Watanabe, T. & Sullenger, B. A. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl Acad. Sci. USA 97, 8490–8494 (2000).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Lan, N., Howrey, R. P., Lee, S. W., Smith, C. A. & Sullenger, B. A. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science 280, 1593–1596 (1998).
  Article ADS CAS PubMed Google Scholar
• Puttaraju, M., Jamison, S. F., Mansfield, S. G., Garcia-Blanco, M. A. & Mitchell, L. G. Spliceosome-mediated RNA _trans_-splicing as a tool for gene therapy. Nature Biotechnol. 17, 246–252 (1999).
  Article CAS Google Scholar
• Puttaraju, M., DiPasquale, J., Baker, C. C., Mitchell, L. G. & Garcia-Blanco, M. A. Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing. Mol. Ther. 4, 105–114 (2001).
  Article CAS PubMed Google Scholar
• Liu, X. et al. Partial correction of endogenous ΔF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA _trans_-splicing. Nature Biotechnol. 20, 47–52 (2002).
  Article CAS Google Scholar
• Kikumori, T., Cote, G. J. & Gagel, R. F. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy? Hum. Gene Ther. 12, 1429–1441 (2001).
  Article CAS PubMed Google Scholar
• Kohler, U., Ayre, B. G., Goodman, H. M. & Haseloff, J. Trans-splicing ribozymes for targeted gene delivery. J. Mol. Biol. 285, 1935–1950 (1999).
  Article CAS PubMed Google Scholar
• Ayre, B. G., Kohler, U., Goodman, H. M. & Haseloff, J. Design of highly specific cytotoxins by using trans-splicing ribozymes. Proc. Natl Acad. Sci. USA 96, 3507–3512 (1999).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Zarrinkar, P. P. & Sullenger, B. A. Optimizing the substrate specificity of a group I intron ribozyme. Biochemistry 38, 3426–3432 (1999).
  Article CAS PubMed Google Scholar
• Sullenger, B. A., Gallardo, H. F., Ungers, G. E. & Gilboa, E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601–608 (1990).
  Article CAS PubMed Google Scholar
• Lee, T. C., Sullenger, B. A., Gallardo, H. F., Ungers, G. E. & Gilboa, E. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4, 66–74 (1992).
  CAS PubMed Google Scholar
• Kohn, D. B. et al. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34+ cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 94, 368–371 (1999).
  Article CAS PubMed Google Scholar
• Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990).
  Article ADS CAS PubMed Google Scholar
• Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818–822 (1990).
  Article ADS CAS PubMed Google Scholar
• Gold, L., Polisky, B., Uhlenbeck, O. & Yarus, M. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64, 763–797 (1995).
  Article CAS PubMed Google Scholar
• White, R. R., Sullenger, B. A. & Rusconi, C. P. Developing aptamers into therapeutics. J. Clin. Invest. 106, 929–934 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Jellinek, D. et al. Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34, 11363–11372 (1995).
  Article CAS PubMed Google Scholar
• Ruckman, J. et al. 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273, 20556–20567 (1998).
  Article CAS PubMed Google Scholar
• Hicke, B. J. & Stephens, A. W. Escort aptamers: a delivery service for diagnosis and therapy. J. Clin. Invest. 106, 923–928 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H. & Toole, J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564–566 (1992).
  Article ADS CAS PubMed Google Scholar
• Griffin, L. C., Tidmarsh, G. F., Bock, L. C., Toole, J. J. & Leung, L. L. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 81, 3271–3276 (1993).
  Article CAS PubMed Google Scholar
• DeAnda, A. Jr et al. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. Ann. Thoracic Surg. 58, 344–350 (1994).
  Article Google Scholar
• Ostendorf, T. et al. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 12, 909–918 (2001).
  Article CAS PubMed Google Scholar
• Drolet, D. W. et al. Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm. Res. 17, 1503–1510 (2000).
  Article CAS PubMed Google Scholar
• Yewdell, J. W., Norbury, C. C. & Bennink, J. R. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73, 1–77 (1999).
  Article CAS PubMed Google Scholar
• Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
  Article ADS CAS PubMed Google Scholar
• Boczkowski, D., Nair, S. K., Snyder, D. & Gilboa, E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465–472 (1996).
  Article CAS PubMed Google Scholar
• Koido, S. et al. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J. Immunol. 165, 5713–5719 (2000).
  Article CAS PubMed Google Scholar
• Granstein, R. D., Ding, W. & Ozawa, H. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. J. Invest. Dermatol. 114, 632–636 (2000).
  Article CAS PubMed Google Scholar
• Zhang, W. et al. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin. Hum. Gene Ther. 10, 1151–1161 (1999).
  Article ADS CAS PubMed Google Scholar
• Boczkowski, D., Nair, S. K., Nam, J. H., Lyerly, H. K., & Gilboa, E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res. 60, 1028–1034 (2000).
  CAS PubMed Google Scholar
• Ashley, D. M. et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186, 1177–1182 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Nair, S. K. et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nature Med. 6, 1011–1017 (2000)
  Article CAS PubMed Google Scholar
• Weissman, D. et al. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J. Immunol. 165, 4710–4717 (2000).
  Article CAS PubMed Google Scholar
• Van Tendeloo, V. et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98, 49–56 (2001).
  Article CAS PubMed Google Scholar
• Su, Z., Peluso, M. V., Raffegerst, S. H., Schendel, D. J. & Roskrow, M. A. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease. Eur. J. Immunol. 31, 947–958 (2001).
  Article CAS PubMed Google Scholar
• Strobel, I. et al. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Ther. 7, 2028–2035 (2000).
  Article CAS PubMed Google Scholar
• Saeboe-Larssen, S., Fossberg, E. & Gaudernack, G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J. Immunol. Meth. 259, 191–203 (2002).
  Article CAS Google Scholar
• Heiser, A. et al. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res. 61, 3388–3393 (2001).
  CAS PubMed Google Scholar
• Heiser, A. et al. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J. Immunol. 166, 2953–2960 (2001).
  Article CAS PubMed Google Scholar
• Heiser, A. et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J. Immunol. 164, 5508–5514 (2000).
  Article CAS PubMed Google Scholar
• Thornburg, C., Boczkowski, D., Gilboa, E. & Nair, S. K. Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. J. Immunother. 23, 412–418 (2000).
  Article CAS PubMed Google Scholar
• Nair, S. K. et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnol. 16, 364–369 (1998).
  Article CAS Google Scholar
• Srivastava, P. K. Do human cancers express shared protective antigens? Or the necessity of remembrance of things past. Semin. Immunol. 8, 295–302 (1996).
  Article CAS PubMed Google Scholar
• Gilboa, E. The makings of a tumor rejection antigen. Immunity 11, 263–270 (1999).
  Article CAS PubMed Google Scholar
• Heiser, A. et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J. Clin. Invest. 109, 409–417 (2002).
  Article CAS PubMed PubMed Central Google Scholar